anonymous
Guest
anonymous
Guest
Anybody have some info ? It’s been very quiet,
Waiting for 3 things: analyze calibration data; early competition sales data; SD to make a decision.
Ironically, the better the competition does at the start, the better chance more keep our jobs.
What about other business units?
Health systems is on the radarHosptal and Oncolgy rumors both ways. Being evaluated.
Telling that Japan ups our 5yr goals for Fezo by another 1$b and yet we continue to downsize PCP. Early indicator this will be highly targeted Specialty marketing and not shotgunning PCPs. Will we even have a PCP force, or will we just move some to Specialty and cover high decile PCP with them? Over/Under of 225 in Women's Health Care Team announced for 2022FY. That would mean a further reduction of 125 from current Spec/PCP team. We just absorbed 75 PCP/Spec spots, more to absorb next year. If layoffs have to occur, hopefully they will get rid of deadwood in both PCP and Spec. Less RSM and ASD spots needed too, lots of dry kindling there. Less promotion opportunities for rep to manager spots. The brightest spot is more promotions to Oncology will occur as those reps jump ship to other Oncology companies for $30k raises.
Doesn’t make sense, downsizing for a huge launch? Billions at stake?
Explain the rationale for just absorbing 70 territories then.
Old Pharma = Multiple Reps per smaller territory calling on any doc they can see, many of whom are easier to see with little potential = massive waste of time and resources.
New Pharma = One Rep per larger territory calling on high value docs only = higher return on time investment and increased profitablity.
Our PCP sales force is half what it was 6 years ago and our sales in PCP continue to go up. Explain that contradiction since you advocate bigger is better for Fezo?
We can always add later if we want to go after the massive amount of low decile deadwood docs.
Exactly my point, traditionally, you start big, then taper off on headcount in line with lifecycle of drug.....so, to start smaller and add as needed doesn’t make sense . You have one shot to launch fezo right.
The future is virtualDigital.
Key word is 'traditionally'. Small territories, multiple reps, and calling on everyone is a dead concept. Smaller force, larger territories and targeted selling is the new focus. Reps who are traditional in their process, and unwilling to change and learn to target, will be obsolete. Enjoy working at Bubba's Used Cars next year.